title: Can objective endpoints be manipulated in unmasked trials?
authors.forename: Vance W
authors.initials: VW
authors.lastname: Berger
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000592:standards*; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D004364:Pharmaceutical Preparations